Cricket players at a certain level are required to submit a TUE application if they wish to use a prohibited substance or method to treat a legitimate medical condition.
An international level player is required to apply to ICC and a national level player to UKAD.
There are two types of TUE application form, Standard and Beta-2 Agonist. Both types of application must be supported by detailed medical history and clinical evidence to be considered by the relevant TUE Committee.
There are four main considerations that will be made by the TUE Committee in relation to an application.
1) Impairment to athlete’s health if the treatment is withheld.
2) Treatment does not enhance performance directly.
3) No alternative therapy available that is not prohibited.
4) Necessity for the treatment does not stem from previous use of a prohibited substance.
From 1st January 2012 the therapeutic use of non-systemic glucocorticosteroid injections and glucocorticosteroid inhalers no longer require a TUE or online declaration.
The Beta-2 Agonist inhalers salbutamol and salmeterol (maximum therapeutic threshold of 1600 micrograms in 24 hours) along with formoterol (maximum therapeutic threshold of 46 micrograms in 24 hours) do not require a TUE or online declaration either. Please note that other longer acting Beta-2 Agonist inhalers such as terbutaline still require a TUE.
Currently only players at the following levels of competition must hold a valid TUE prior to testing:
- England Representative Teams
- First Class Counties – 1st XI
Players representing their County 2nd XI, Academy, Kia Super League or Women’s County side may apply for a TUE retroactively within 10 working days of their selection for testing.
Further information on TUE, guidance notes and resources can be found in the TUE section of the UKAD website. If you have any questions about TUE applications please contact the ECB Anti-Doping Manager directly.